9-Amino-1,2,3,4-tetrahydroacridine is a potent inhibitor of histamine N-methyltransferase

Masahiro Nishibori, R. Oishi, Y. Itoh, K. Saeki

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

The effect of 9-amino-1,2,3,4-tetrahydroacridine (THA) on histamine N-methyltransferase (HMT), an enzyme catalyzing the methylation of histamine to form tele-methylhistamine in the brain, was studied in vitro using a partially purified enzyme preparation from bovine brain and in vivo in the mouse brain. THA inhibited the HMT activity in competitive and non-competitive mixed type manners with respect to histamine. The K(i) and K(i), values were 75 nM and 1.2 μM, respectively. The IC50 values for THA, 9-aminoacridine and physostigmine in the inhibition of HMT determined at fixed concentrations of histamine (20 μM) and S-adenosylmethionine (50 μM) were 0.2, 0.37 and 20 μM, respectively. Neostigmine exhibited only 15% inhibition even at a concentration of 100 μM. THA (2-10 mg/kg, s.c.) dose-dependently inhibited HMT in the mouse brain. The inhibition of HMT by THA (10 mg/kg) was marked at 30 and 60 min after treatment, but disappeared by 120 min after. THA (10 mg/kg) significantly increased the histamine level and decreased the tele-methylhistamine level in the mouse brain. These results indicate that THA is a potent inhibitor of HMT.

Original languageEnglish
Pages (from-to)539-546
Number of pages8
JournalJapanese Journal of Pharmacology
Volume55
Issue number4
Publication statusPublished - 1991

Fingerprint

Histamine N-Methyltransferase
Tacrine
Histamine
Brain
Aminacrine
Neostigmine
S-Adenosylmethionine
Physostigmine
Enzymes
Methylation
Inhibitory Concentration 50

ASJC Scopus subject areas

  • Pharmacology

Cite this

9-Amino-1,2,3,4-tetrahydroacridine is a potent inhibitor of histamine N-methyltransferase. / Nishibori, Masahiro; Oishi, R.; Itoh, Y.; Saeki, K.

In: Japanese Journal of Pharmacology, Vol. 55, No. 4, 1991, p. 539-546.

Research output: Contribution to journalArticle

@article{b7e504c0e4394fcfbc9e3c73b9827f2b,
title = "9-Amino-1,2,3,4-tetrahydroacridine is a potent inhibitor of histamine N-methyltransferase",
abstract = "The effect of 9-amino-1,2,3,4-tetrahydroacridine (THA) on histamine N-methyltransferase (HMT), an enzyme catalyzing the methylation of histamine to form tele-methylhistamine in the brain, was studied in vitro using a partially purified enzyme preparation from bovine brain and in vivo in the mouse brain. THA inhibited the HMT activity in competitive and non-competitive mixed type manners with respect to histamine. The K(i) and K(i), values were 75 nM and 1.2 μM, respectively. The IC50 values for THA, 9-aminoacridine and physostigmine in the inhibition of HMT determined at fixed concentrations of histamine (20 μM) and S-adenosylmethionine (50 μM) were 0.2, 0.37 and 20 μM, respectively. Neostigmine exhibited only 15{\%} inhibition even at a concentration of 100 μM. THA (2-10 mg/kg, s.c.) dose-dependently inhibited HMT in the mouse brain. The inhibition of HMT by THA (10 mg/kg) was marked at 30 and 60 min after treatment, but disappeared by 120 min after. THA (10 mg/kg) significantly increased the histamine level and decreased the tele-methylhistamine level in the mouse brain. These results indicate that THA is a potent inhibitor of HMT.",
author = "Masahiro Nishibori and R. Oishi and Y. Itoh and K. Saeki",
year = "1991",
language = "English",
volume = "55",
pages = "539--546",
journal = "Japanese Journal of Pharmacology",
issn = "0021-5198",
publisher = "Japanese Pharmacological Society",
number = "4",

}

TY - JOUR

T1 - 9-Amino-1,2,3,4-tetrahydroacridine is a potent inhibitor of histamine N-methyltransferase

AU - Nishibori, Masahiro

AU - Oishi, R.

AU - Itoh, Y.

AU - Saeki, K.

PY - 1991

Y1 - 1991

N2 - The effect of 9-amino-1,2,3,4-tetrahydroacridine (THA) on histamine N-methyltransferase (HMT), an enzyme catalyzing the methylation of histamine to form tele-methylhistamine in the brain, was studied in vitro using a partially purified enzyme preparation from bovine brain and in vivo in the mouse brain. THA inhibited the HMT activity in competitive and non-competitive mixed type manners with respect to histamine. The K(i) and K(i), values were 75 nM and 1.2 μM, respectively. The IC50 values for THA, 9-aminoacridine and physostigmine in the inhibition of HMT determined at fixed concentrations of histamine (20 μM) and S-adenosylmethionine (50 μM) were 0.2, 0.37 and 20 μM, respectively. Neostigmine exhibited only 15% inhibition even at a concentration of 100 μM. THA (2-10 mg/kg, s.c.) dose-dependently inhibited HMT in the mouse brain. The inhibition of HMT by THA (10 mg/kg) was marked at 30 and 60 min after treatment, but disappeared by 120 min after. THA (10 mg/kg) significantly increased the histamine level and decreased the tele-methylhistamine level in the mouse brain. These results indicate that THA is a potent inhibitor of HMT.

AB - The effect of 9-amino-1,2,3,4-tetrahydroacridine (THA) on histamine N-methyltransferase (HMT), an enzyme catalyzing the methylation of histamine to form tele-methylhistamine in the brain, was studied in vitro using a partially purified enzyme preparation from bovine brain and in vivo in the mouse brain. THA inhibited the HMT activity in competitive and non-competitive mixed type manners with respect to histamine. The K(i) and K(i), values were 75 nM and 1.2 μM, respectively. The IC50 values for THA, 9-aminoacridine and physostigmine in the inhibition of HMT determined at fixed concentrations of histamine (20 μM) and S-adenosylmethionine (50 μM) were 0.2, 0.37 and 20 μM, respectively. Neostigmine exhibited only 15% inhibition even at a concentration of 100 μM. THA (2-10 mg/kg, s.c.) dose-dependently inhibited HMT in the mouse brain. The inhibition of HMT by THA (10 mg/kg) was marked at 30 and 60 min after treatment, but disappeared by 120 min after. THA (10 mg/kg) significantly increased the histamine level and decreased the tele-methylhistamine level in the mouse brain. These results indicate that THA is a potent inhibitor of HMT.

UR - http://www.scopus.com/inward/record.url?scp=0025727739&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025727739&partnerID=8YFLogxK

M3 - Article

VL - 55

SP - 539

EP - 546

JO - Japanese Journal of Pharmacology

JF - Japanese Journal of Pharmacology

SN - 0021-5198

IS - 4

ER -